Press Release: April 24th, 2019
Edanz Group Japan Inc. (“edanz”: Fukuoka, Japan; URLs: https://www.edanzwriting.com & https://www.edanzediting.com), the global leader in high-quality scientific and medical research support, has joined M3, Inc. the global leader in healthcare information services, (TSE 2413: Tokyo, Japan; URL: https://corporate.m3.com/; CEO: Itaru Tanimura; “M3” below).
Edanz Group announced this week a new collaboration with ORCID which will make it possible for authors to connect their ORCID iD to the company's Author Path, Author Academy, and Author Services websites.
Koji Yamashita, CEO of Edanz Group, said, "I am excited to work with ORCID to provide the best authoring experiences possible, from author education and manuscript writing, all the way to submitting to journals automatically."
Edanz announced today that it is partnering with Aries Systems in adopting the Editorial Manager Ingest Service for its Author Path product (www.author-path.com).
The Edanz Author Path was launched in beta last April in both English and Chinese. This partnership means authors using the Author Path, will be able to submit files and metadata associated with their manuscripts to the thousands of journals using Editorial Manager with a single click.
FUKUOKA, Japan - Edanz Group is proud to announce the beta launch of the Author Path, a new scientific writing and collaboration tool for researchers and authors specifically developed for non-native English speakers.
Edanz is proud to announce a new collaboration with the American Association for the Advancement of Science (AAAS) to provide language editing services.